Skip to main content
. 2022 Feb 14;28(6):624–634. doi: 10.3748/wjg.v28.i6.624

Figure 3.

Figure 3

Future directions of detection and risk stratification of pancreatic cystic lesion to guide clinical management. PCL: Pancreatic cystic lesion, CEA: Carcinoembryonic antigen, IPMN: Intraductal papillary mucinous neoplasms.